| Alma Rosa Barreto, APRN | |
|
65 Avonwood Rd, Apt C9, Avon, CT 06001-2051 | |
| (203) 559-6525 | |
| Not Available |
| Full Name | Alma Rosa Barreto |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 11 Years |
| Location | 65 Avonwood Rd, Avon, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114462751 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Middlesex Hospital | Middletown, CT | Hospital |
| Entity Name | State Of Connecticut |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902831548 PECOS PAC ID: 8022915677 Enrollment ID: O20040319000291 |
News Archive
A group of researchers at The Scripps Research Institute and the Scripps Translational Science Institute has published a paper that reviews new strategies for identifying collections of rare genetic variations that reveal whether people are predisposed to developing common conditions like diabetes and cancer.
Neuraltus Pharmaceuticals, Inc., a privately-held biopharmaceutical company focused on the development of groundbreaking drugs to treat neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), announced today that Robert G. Miller, M.D., Director of the Forbes Norris MDA/ALS Research Center at Sutter Health's California Pacific Medical Center in San Francisco, has been awarded a grant from The ALS Association for $1.5 million to help fund a Phase 2 clinical study of the company's investigational therapy for ALS, NP001.
General Dynamics has entered a definitive agreement to acquire Vangent Holding Corp., the parent company of Vangent, Inc., a leading provider of healthcare information-technology and business systems to federal agencies, in a cash transaction valued at approximately $960 million.
Each year 170,000 people around the world die of this type of meningitis, according to the World Health Organization, (WHO).
Health officials in Abu Dhabi announced at a forum that there is an exponential rise in the number of obese and overweight children in the country. The country is gearing up to tackle this problem to reduce the body mass index (BMI) of the children by at least 15 percent by the year 2020.
› Verified 1 days ago
| Entity Name | State Of Connecticut |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427074426 PECOS PAC ID: 8022915677 Enrollment ID: O20040319000365 |
News Archive
A group of researchers at The Scripps Research Institute and the Scripps Translational Science Institute has published a paper that reviews new strategies for identifying collections of rare genetic variations that reveal whether people are predisposed to developing common conditions like diabetes and cancer.
Neuraltus Pharmaceuticals, Inc., a privately-held biopharmaceutical company focused on the development of groundbreaking drugs to treat neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), announced today that Robert G. Miller, M.D., Director of the Forbes Norris MDA/ALS Research Center at Sutter Health's California Pacific Medical Center in San Francisco, has been awarded a grant from The ALS Association for $1.5 million to help fund a Phase 2 clinical study of the company's investigational therapy for ALS, NP001.
General Dynamics has entered a definitive agreement to acquire Vangent Holding Corp., the parent company of Vangent, Inc., a leading provider of healthcare information-technology and business systems to federal agencies, in a cash transaction valued at approximately $960 million.
Each year 170,000 people around the world die of this type of meningitis, according to the World Health Organization, (WHO).
Health officials in Abu Dhabi announced at a forum that there is an exponential rise in the number of obese and overweight children in the country. The country is gearing up to tackle this problem to reduce the body mass index (BMI) of the children by at least 15 percent by the year 2020.
› Verified 1 days ago
| Entity Name | Alma Barreto Aprn Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679108534 PECOS PAC ID: 8820429855 Enrollment ID: O20200507001384 |
News Archive
A group of researchers at The Scripps Research Institute and the Scripps Translational Science Institute has published a paper that reviews new strategies for identifying collections of rare genetic variations that reveal whether people are predisposed to developing common conditions like diabetes and cancer.
Neuraltus Pharmaceuticals, Inc., a privately-held biopharmaceutical company focused on the development of groundbreaking drugs to treat neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), announced today that Robert G. Miller, M.D., Director of the Forbes Norris MDA/ALS Research Center at Sutter Health's California Pacific Medical Center in San Francisco, has been awarded a grant from The ALS Association for $1.5 million to help fund a Phase 2 clinical study of the company's investigational therapy for ALS, NP001.
General Dynamics has entered a definitive agreement to acquire Vangent Holding Corp., the parent company of Vangent, Inc., a leading provider of healthcare information-technology and business systems to federal agencies, in a cash transaction valued at approximately $960 million.
Each year 170,000 people around the world die of this type of meningitis, according to the World Health Organization, (WHO).
Health officials in Abu Dhabi announced at a forum that there is an exponential rise in the number of obese and overweight children in the country. The country is gearing up to tackle this problem to reduce the body mass index (BMI) of the children by at least 15 percent by the year 2020.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alma Rosa Barreto, APRN 401 W Thames St, Bldg 301, Norwich, CT 06360-7155 Ph: (860) 859-4674 | Alma Rosa Barreto, APRN 65 Avonwood Rd, Apt C9, Avon, CT 06001-2051 Ph: (203) 559-6525 |
News Archive
A group of researchers at The Scripps Research Institute and the Scripps Translational Science Institute has published a paper that reviews new strategies for identifying collections of rare genetic variations that reveal whether people are predisposed to developing common conditions like diabetes and cancer.
Neuraltus Pharmaceuticals, Inc., a privately-held biopharmaceutical company focused on the development of groundbreaking drugs to treat neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), announced today that Robert G. Miller, M.D., Director of the Forbes Norris MDA/ALS Research Center at Sutter Health's California Pacific Medical Center in San Francisco, has been awarded a grant from The ALS Association for $1.5 million to help fund a Phase 2 clinical study of the company's investigational therapy for ALS, NP001.
General Dynamics has entered a definitive agreement to acquire Vangent Holding Corp., the parent company of Vangent, Inc., a leading provider of healthcare information-technology and business systems to federal agencies, in a cash transaction valued at approximately $960 million.
Each year 170,000 people around the world die of this type of meningitis, according to the World Health Organization, (WHO).
Health officials in Abu Dhabi announced at a forum that there is an exponential rise in the number of obese and overweight children in the country. The country is gearing up to tackle this problem to reduce the body mass index (BMI) of the children by at least 15 percent by the year 2020.
› Verified 1 days ago